Citron Shorts VCX, Calls On SEC To Investigate If Fundrise Is Paying Influencers To Promote The Fund
Citron Research shorted Fundrise Innovation Fund (VCX), citing a $400 trading price vs. $19 asset value. They urged SEC to investigate potential influencer payments by Fundrise. VCX dropped 37% on the news. Citron compared VCX to Destiny Tech100 (DXYZ), which also invests in private tech companies and trades at a premium.
How this was made
The 30-second read
Why it matters
The short claim and call for regulator action have already triggered a 37% opening decline, suggesting heightened volatility.
Market read
The article introduces a fresh catalyst for VCX's price drop and may prompt further regulatory scrutiny of similar funds.
What to watch
Potential hidden NAV adjustments or upcoming fund redemptions that could stabilize price.
Background
Citron Research, a known short‑seller, targeted VCX after noting a large premium to NAV and past SEC charges against its sponsor.
Ticker impact
Citron Research announced a short position in Fundrise Innovation Fund (VCX) and highlighted a 37% opening drop, urging SEC investigation into influencer promotions.
likely further downside as market prices in short‑seller allegations and potential regulatory scrutiny.
The article is the first report of Citron's short stance and a 37% price plunge, which typically fuels additional selling.
Market effects
Highlights risk for other public venture funds and AI‑focused ETFs that may face similar scrutiny.
Primarily affects US‑listed micro‑cap investors; limited broader regional effect.
Minimal global impact beyond niche venture‑fund investors.
Counterpoint
If the SEC finds no wrongdoing, the short could be a temporary overreaction and VCX may rebound.
Key entities
- FundFundrise Innovation Fund
Public venture fund (ticker VCX) exposing investors to private tech companies.
- Short‑sellerCitron Research
Activist short‑seller publishing the allegations.

